Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Radiographic Versus Pathology-Integrated Response for Assessing Optimal Surgical Timing After Neoadjuvant Imatinib in Patients With Locally Advanced KIT Exon 11-Mutant GIST.
Journal: Annals of surgery
Published: April 06, 2026
Preoperative Avapritinib for Localized PDGFRA-Mutant GIST: Marked Pathologic Response, but Limited Feasibility at Standard Dosing.
Journal: Cancer medicine
Published: January 05, 2026
Cytoreductive Surgery in Patients With Metastatic Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumors.
Journal: Journal of surgical oncology
Published: November 16, 2025
Characterization of Patients with Unresectable Hepatocellular Carcinoma in REFLECT Who Achieved Tumor Response or Alpha-Fetoprotein Response When Treated with Lenvatinib.
Journal: Liver cancer
Published: October 24, 2025
Stoking an anti-liver cancer immune response with cryoablation plus an intratumoral TLR9 agonist and dual checkpoint inhibitors.
Journal: Cancer immunology, immunotherapy : CII
Published: October 08, 2025
Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: September 10, 2025
Early Safety Results from the Phase 3b SIERRA Study of Durvalumab and Tremelimumab as First-Line Treatment for Participants with Unresectable Hepatocellular Carcinoma and a Poor Prognosis.
Journal: Liver cancer
Published: August 26, 2025
Hyperprogression and Systemic Metastasis of Cholangiocarcinoma after Histotripsy Therapy.
Journal: Journal of vascular and interventional radiology : JVIR
Published: May 09, 2025
Blood microbial DNA signature differentiates hepatocellular carcinoma from metastatic lesions.
Journal: eGastroenterology
Published: February 06, 2025
Cabozantinib plus atezolizumab in previously untreated advanced hepatocellular carcinoma and previously treated gastric cancer and gastroesophageal junction adenocarcinoma: results from two expansion cohorts of a multicentre, open-label, phase 1b trial (COSMIC-021).
Journal: EClinicalMedicine
Published: September 08, 2023
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 11, 2023
Last Updated: 09/26/2026